Get access

Delta-F508 cystic fibrosis mutation is not linked to intussusception: Implications for rotavirus vaccine

Authors


Dr G Barnes, Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Vic. 3052, Australia. Fax: +61 3 9345 6240; email: graeme.barnes@rch.org.au

Abstract

Objective: To determine whether the cystic fibrosis (CF) delta-F508 gene mutation predisposes to intussusception, and so selects infants who should not receive rotavirus vaccine.

Methods:  Stored neonatal screening blood spots, retrieved from 81 infants with intussusception and from 79 controls, were tested for the presence of the CF delta-F508 gene mutation.

Results:  Prevalence of the mutation was similar in blood specimens from intussusception patients and from controls.

Conclusion: Testing for the CF delta-F508 mutation at birth is unlikely to identify infants predisposed to intussusception, and therefore is not relevant to rotavirus vaccine programs.

Get access to the full text of this article

Ancillary